Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)
CNY 18.9
(-0.37%)
CNY 18.9
(-0.37%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 255.27 Million CNY | -13.79% |
| 2022 | 240.05 Million CNY | 24.73% |
| 2021 | 192.45 Million CNY | 22.24% |
| 2020 | 157.43 Million CNY | 32.47% |
| 2019 | 118.84 Million CNY | 9.76% |
| 2018 | 108.27 Million CNY | 20.36% |
| 2017 | 89.95 Million CNY | 19.72% |
| 2016 | 75.13 Million CNY | 0.0% |
| 2014 | 58.33 Million CNY | 16.08% |
| 2013 | 50.25 Million CNY | 32.5% |
| 2012 | 37.92 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 29.01 Million CNY | -41.76% |
| 2024 Q2 | 52.26 Million CNY | 80.12% |
| 2024 Q3 | 37.94 Million CNY | -27.4% |
| 2023 Q2 | 69.09 Million CNY | -11.33% |
| 2023 Q3 | 44.31 Million CNY | -35.87% |
| 2023 Q4 | 49.82 Million CNY | 12.44% |
| 2023 FY | 206.94 Million CNY | -13.79% |
| 2023 Q1 | 77.92 Million CNY | 71.87% |
| 2022 Q3 | 82.67 Million CNY | 44.71% |
| 2022 FY | 240.05 Million CNY | 24.73% |
| 2022 Q4 | 45.33 Million CNY | -45.16% |
| 2022 Q2 | 57.12 Million CNY | 4.03% |
| 2022 Q1 | 54.91 Million CNY | 7.02% |
| 2021 Q2 | 45.09 Million CNY | -5.66% |
| 2021 Q1 | 47.79 Million CNY | 16.04% |
| 2021 Q4 | 51.31 Million CNY | 6.36% |
| 2021 FY | 192.45 Million CNY | 22.24% |
| 2021 Q3 | 48.24 Million CNY | 7.0% |
| 2020 Q3 | 38.57 Million CNY | -10.6% |
| 2020 Q1 | 34.52 Million CNY | 22.89% |
| 2020 FY | 157.43 Million CNY | 32.47% |
| 2020 Q2 | 43.14 Million CNY | 24.96% |
| 2020 Q4 | 41.19 Million CNY | 6.79% |
| 2019 Q2 | 28.18 Million CNY | 0.0% |
| 2019 FY | 118.84 Million CNY | 9.76% |
| 2019 Q4 | 28.09 Million CNY | -8.54% |
| 2019 Q3 | 30.71 Million CNY | 8.99% |
| 2019 Q1 | 28.18 Million CNY | 0.0% |
| 2018 FY | 108.27 Million CNY | 20.36% |
| 2017 FY | 89.95 Million CNY | 19.72% |
| 2016 FY | 75.13 Million CNY | 0.0% |
| 2014 FY | 58.33 Million CNY | 16.08% |
| 2013 FY | 50.25 Million CNY | 32.5% |
| 2012 FY | 37.92 Million CNY | 0.0% |